The Public Must Question the Efficacy of UNAIR’s COVID-19 Drug

Jakarta, IDN Times – Epidemiologist from the Faculty of Public Health, University of Indonesia, Dr. Pandu Riono regretted why the media was not critical and questioned the efficacy of the COVID-19 drug made by Airlangga University researchers by cooperating with the State Intelligence Agency and BNPB. Last (12/6), Chair of the Airlangga University Stem Cell Research and Development Center, Dr. Purwati claims the drug that reads “COVID-19” in his box is effective for killing diseases caused by the Sars-CoV-2 virus.

According to Pandu, the way the media participated in promoting the drug caused the wrong mindset in the community. It is as if a drug to recover COVID-19 patients has been found.

“It should be questioned whether the drug is really useful, so that it could become a big issue. Finally, the government must intervene and say the claim is not true. It is just a puyer concoction and is set. IDN Times with the headline “100 Days Global Pandemic – Workshop Covering COVID-19” which aired online on YouTube last (6/20).

According to Pandu, there was nothing in the box that was claimed to have the COVID-19 drug. Only the box is empty.

“Everyone then believes that it will be produced (in large quantities) and so on,” he said again.

Then, what said BIN who was involved in the process of producing the drug? Why can government institutions in the field of intelligence be involved in overcoming the COVID-19 pandemic?

1. BIN claims the COVID-19 drug studied by Airlangga has cured the patient

Researchers at Airlangga University (Airlangga University) together with the National Intelligence Agency (BIN) and the National Task Force continue to research COVID-19 healing recipes (Doc.IDN Times / BNPB)

When giving a press statement on (12/6) then, Dr. Purwati said, the five drugs that were being studied by Unair and claimed to be effective in curing COVID-19 patients were taken from a study of 14 drug combination regimens that had been circulating on the market.

“We examine the potential and effectiveness of the drug so that the indications are expanded to become drugs that have antiviral effects from SARSCOVID2 by handling COVID-19 based on viruses in Indonesia through a series of processes,” Purwati said at the BNPB Building.

He then explained five types of combinations of drug regimens that are on the market and claimed to be successfully tested in COVID-19 patients, namely:

  1. Lopinavir / ritonavir with azithromicyne
  2. Lopinavir / ritonavir with doxycyline
  3. Lopinavir / ritonavir with chlaritromycine
  4. Hydroxychloroquine with azithromicyne
  5. Hydroxychloroquine with doxycycline

On the official website of the Airlangga University, Purwati underlined the combination regimen was not yet traded freely.

“(The drug regimen) has not yet been traded. This is a collaboration between Unair, BNPB and also the State Intelligence Agency (BIN),” he said again.

Meanwhile, when confirmed to the spokesperson of the Head of BIN, Wawan Purwanto, he did not dismiss the institution where he worked helped assist the research conducted by Airlangga University. However, he said not only research at Airlangga was supported by BIN. Other campuses are also supported by BIN. It’s just not as fast as Unair conveyed to the public.

“Many universities, laboratories and hospitals (which we support),” said Henry when contacted by IDN Times on Monday night (6/22).

BIN, Wawan continued, providing support to Unair in the form of equipment for laboratories, including reagents. Henry even claimed that the COVID-19 drug had been given to patients at the Airlangga University and many were recovered. However, when asked how many patients were recovered, Henry claimed to have to double check the data.

“So far, the only patients (COVID-19 drug) given (treated) are at Airlangga Hospital,” he said.

IDN Times also tried to contact dr. Purwati either by telephone or short message to ensure the data, but not responded.

Continue reading the article below

Editor’s picks

Also Read: UNAIR-BIN Researchers Produce 5 Effective Drug Combinations to Kill COVID-19

2. Five COVID-19 drug combinations have been tested in the Airlangga laboratory

UI Plague Officer: Public Must Question the Efficacy of UNAIR COVID-19 DrugResearch on COVID-19 healing recipes continues to be pursued (Doc.IDN Times / BNPB)

Through telephone conversations, Henry also mentioned that the five drug combinations had been tested in a laboratory at Airlangga University. In fact, he said, the BIN and Unair had communicated with the Food and Drug Supervisory Agency (BPOM) to obtain certification so that it could be mass produced.

“Later the legality will be at BPOM. We will return it to BPOM (to provide certification),” he said.

Interestingly, despite Wawan knowing the drug has not pocketed certification from BPOM, but still given to patients with COVID-19 disease. Because, until now, there has not been a single official drug approved by the World Health Organization (WHO) to cure the disease.

“Yes, our findings, yes we still do with findings like this (giving five combinations of drugs). Other parties are welcome when using their own methods,” he said again.

3. UI epidemiologist assessed that the five combinations of COVID-19 drug from Airlangga University were very forced

UI Plague Officer: Public Must Question the Efficacy of UNAIR's COVID-19 DrugDr. Guide Riono in an exciting Chat by IDN Times with the theme “100 Days of the Globql Pandemic: Workshop Covering COVID-19”. IDN Times / Besse Fadhilah

Meanwhile, Dr. Pandu admitted that he was worried by the presence of five combinations of COVID-19 drugs made by Airlangga, the hospital would later be forced to take the drug. In fact, its efficacy has not been properly tested.

“So this seems to force it to be bought (the medicine) so that hospitals use it. That is one quick way to benefit from this loose public funding,” he said.

Pandu’s greater concern is the existence of corruption in the name of the public interest of this pandemic.

4. BIN intervened to overcome the pandemic because there is one indication of this biological war

UI Plague Officer: Public Must Question the Efficacy of UNAIR's COVID-19 Drug(Illustration of corona virus) IDN Times / Arief Rahmat

Meanwhile, when asked why the intelligence services had to intervene to deal with the pandemic issue, Wawan said this situation was included in BIN’s task, especially in the defense sector. Because, he said, there were indications that this pandemic was part of biological warfare.

“However, we are still doing further deepening. Inside BIN there are nuclear, biological and chemical units. So, from the nuclear unit intervened including deploying observation equipment that is applied in all regions, especially the red and black zones,” said Henry.

BIN also analyzed where the pandemic came from, the extent of vulnerability to the description of its distribution in Indonesia.

“The nubika unit (nuclear, biology, chemistry) always sterilizes the area that is a threat. We always give reports to the leadership of BIN, from there the report is forwarded by the leadership of BIN to the President,” he said again.

Also Read: UI Epidoteist: RI Has Not Entered the Peak of the First Wave of COVID-19

Leave a Comment